A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy... | NCT02047422 | Trialant
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
ClinicalTrials.gov ID
NCT02047422
Lead Sponsor
Yonsei UniversityOTHER
Overall Status
Withdrawn
Study Type
Interventional
Phase
Not Applicable
Enrollment
0Actual
Last Update Posted
Sep 7, 2016Estimated
Start Date
Jan 2014
Primary Completion Date
Feb 2016Estimated
Completion Date
Feb 2016Estimated
Brief Summary
To compare the effectiveness and safety of diuretics add-on strategy in chronic heart failure patients
Congestive Heart Failure
Furosemide
metolazone
furosemid/spironolactone
metolazone/spironolactone
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
dyspnea at rest or minimal activity
tachypnea (respiratory rate > 20/min) or rales or pulmonary edema on chest X-ray
Exclusion Criteria:
hospitalization for acute heart failure decompensation